These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 25954998)

  • 21. Substrate recognition of VAMP-2 by botulinum neurotoxin B and tetanus neurotoxin.
    Chen S; Hall C; Barbieri JT
    J Biol Chem; 2008 Jul; 283(30):21153-9. PubMed ID: 18511417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery from botulinum neurotoxin poisoning in vivo.
    Keller JE
    Neuroscience; 2006 May; 139(2):629-37. PubMed ID: 16490322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Conservation of Tetanus and Botulinum Neurotoxins Cleavage Sites on Human SNARE Proteins Suggests That These Pathogens Exerted Little or No Evolutionary Pressure on Humans.
    Carle S; Pirazzini M; Rossetto O; Barth H; Montecucco C
    Toxins (Basel); 2017 Dec; 9(12):. PubMed ID: 29257047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.
    Schiavo G; Rossetto O; Catsicas S; Polverino de Laureto P; DasGupta BR; Benfenati F; Montecucco C
    J Biol Chem; 1993 Nov; 268(32):23784-7. PubMed ID: 8226912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of the HA-33 protein in botulinum neurotoxin type G complex by mass spectrometry.
    Kalb SR; Baudys J; Barr JR
    BMC Microbiol; 2015 Oct; 15():227. PubMed ID: 26494251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Universal and specific quantitative detection of botulinum neurotoxin genes.
    Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC
    BMC Microbiol; 2010 Oct; 10():267. PubMed ID: 20961439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clostridium botulinum neurotoxin type B is heat-stable in milk and not inactivated by pasteurization.
    Rasooly R; Do PM
    J Agric Food Chem; 2010 Dec; 58(23):12557-61. PubMed ID: 21053906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure of botulinum neurotoxin type D light chain at 1.65 A resolution: repercussions for VAMP-2 substrate specificity.
    Arndt JW; Chai Q; Christian T; Stevens RC
    Biochemistry; 2006 Mar; 45(10):3255-62. PubMed ID: 16519520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitive detection of type G botulinum neurotoxin through Endopep-MS peptide substrate optimization.
    Wang D; Baudys J; Hoyt K; Barr JR; Kalb SR
    Anal Bioanal Chem; 2019 Aug; 411(21):5489-5497. PubMed ID: 31172236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current Developments in Diagnostic Assays for Laboratory Confirmation and Investigation of Botulism.
    Centurioni DA; Egan CT; Perry MJ
    J Clin Microbiol; 2022 Apr; 60(4):e0013920. PubMed ID: 34586891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum neurotoxin detection and differentiation by mass spectrometry.
    Barr JR; Moura H; Boyer AE; Woolfitt AR; Kalb SR; Pavlopoulos A; McWilliams LG; Schmidt JG; Martinez RA; Ashley DL
    Emerg Infect Dis; 2005 Oct; 11(10):1578-83. PubMed ID: 16318699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Novel Surface Plasmon Resonance Biosensor for the Rapid Detection of Botulinum Neurotoxins.
    Patel K; Halevi S; Melman P; Schwartz J; Cai S; Singh BR
    Biosensors (Basel); 2017 Aug; 7(3):. PubMed ID: 28783115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A capillary electrophoresis method to assay catalytic activity of botulinum neurotoxin serotypes: implications for substrate specificity.
    Purcell AL; Hoard-Fruchey HM
    Anal Biochem; 2007 Jul; 366(2):207-17. PubMed ID: 17548044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection.
    Rivera VR; Gamez FJ; Keener WK; White JA; Poli MA
    Anal Biochem; 2006 Jun; 353(2):248-56. PubMed ID: 16620745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of tetanus and botulinum neurotoxins.
    Montecucco C; Schiavo G
    Mol Microbiol; 1994 Jul; 13(1):1-8. PubMed ID: 7527117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of peptide substrates for botulinum neurotoxin E improves detection sensitivity in the Endopep-MS assay.
    Wang D; Krilich J; Baudys J; Barr JR; Kalb SR
    Anal Biochem; 2015 Jan; 468():15-21. PubMed ID: 25232998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of immunodetection system for botulinum neurotoxin serotype E.
    Sarita R; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Indian J Med Res; 2018 Jun; 147(6):603-610. PubMed ID: 30168493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The in vitro detection of botulinum neurotoxin-cleaved endogenous VAMP is epitope-dependent.
    Gray B; Cadd V; Elliott M; Beard M
    Toxicol In Vitro; 2018 Apr; 48():255-261. PubMed ID: 29373835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generation and Characterization of Six Recombinant Botulinum Neurotoxins as Reference Material to Serve in an International Proficiency Test.
    Weisemann J; Krez N; Fiebig U; Worbs S; Skiba M; Endermann T; Dorner MB; Bergström T; Muñoz A; Zegers I; Müller C; Jenkinson SP; Avondet MA; Delbrassinne L; Denayer S; Zeleny R; Schimmel H; Åstot C; Dorner BG; Rummel A
    Toxins (Basel); 2015 Nov; 7(12):5035-54. PubMed ID: 26703728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection and Quantification of Biologically Active Botulinum Neurotoxin Serotypes A and B Using a Förster Resonance Energy Transfer-Based Quantum Dot Nanobiosensor.
    Wang Y; Fry HC; Skinner GE; Schill KM; Duncan TV
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31446-31457. PubMed ID: 28840718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.